Archived App (Last seen on 21 May 2025)
This is an archived listing of the app previously available on the App Store.Although the app is no longer distributed by Apple, you can still view its description, screenshots, version history, ratings, and metadata for reference.
About
You are invited to participate in the Neurocrine Biosciences RX-KINECT Participant study to evaluate INGREZZA for the treatment of TD.
This app is specifically intended for study participants in the Neurocrine Biosciences RX-KINECT Participant study only.
The application uses HealthKit and Apple's ResearchKit library to conduct clinical trials.
Show more
What's New in RxKinect
1.0
January 28, 2022
